Sigyn Therapeutics Updates Principal Office, Phone Number

Ticker: SIGY · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1642159

Sigyn Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanySigyn Therapeutics, Inc. (SIGY)
Form Type8-K
Filed DateJan 31, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: administrative-change, corporate-update

TL;DR

**Sigyn Therapeutics moved its main office and changed its phone number, effective January 31, 2024.**

AI Summary

Sigyn Therapeutics, Inc. filed an 8-K on January 31, 2024, to update its principal executive offices from 9190 W Olympic Blvd #263, Beverly Hills, CA 90212 to 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106. This change also includes an update to their business phone number from 619-368-2000 to 619-353-0800. This matters to investors because it signifies a logistical change in the company's operations, potentially indicating a consolidation or relocation of its primary business activities, which could impact overhead or operational efficiency.

Why It Matters

This filing indicates a change in the company's physical headquarters and primary contact number, which could reflect operational restructuring or cost-saving measures. Investors should note this as it might signal underlying shifts in the company's business strategy or footprint.

Risk Assessment

Risk Level: low — The filing only reports a change in address and phone number, which are administrative updates and do not inherently pose significant financial or operational risks.

Analyst Insight

A smart investor would note this administrative change but recognize it likely has minimal direct impact on the company's financial performance or strategic direction. No immediate action is warranted based solely on this filing.

Key Players & Entities

  • Sigyn Therapeutics, Inc. (company) — the registrant filing the 8-K
  • 9190 W Olympic Blvd #263, Beverly Hills, CA 90212 (address) — former principal executive office
  • 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106 (address) — new principal executive office
  • 619-368-2000 (phone_number) — former business phone number
  • 619-353-0800 (phone_number) — new business phone number
  • January 31, 2024 (date) — date of earliest event reported

Forward-Looking Statements

  • The change in address could lead to minor, short-term administrative disruptions. (Sigyn Therapeutics, Inc.) — medium confidence, target: Q1 2024

FAQ

What was the previous principal executive office address for Sigyn Therapeutics, Inc.?

The previous principal executive office address for Sigyn Therapeutics, Inc. was 9190 W Olympic Blvd #263, Beverly Hills, CA 90212.

What is the new principal executive office address for Sigyn Therapeutics, Inc.?

The new principal executive office address for Sigyn Therapeutics, Inc. is 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on January 31, 2024.

What was the former business phone number for Sigyn Therapeutics, Inc.?

The former business phone number for Sigyn Therapeutics, Inc. was 619-368-2000.

What is the new business phone number for Sigyn Therapeutics, Inc.?

The new business phone number for Sigyn Therapeutics, Inc. is 619-353-0800.

Filing Stats: 417 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2024-01-31 16:20:41

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGYN THERAPEUTICS, INC. Date: January 31, 2024 By: /s/ James A. Joyce James A. Joyce, Chairman and CEO

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.